Truist Financial Corp Heron Therapeutics, Inc. Transaction History

Truist Financial Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $85,387 - $128,847	-10,226 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$10.13 - $15.0 $77,747 - $115,125	-7,675 Reduced 42.87%	10,226 $109,000
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $3,981 - $5,544	300 Added 1.7%	17,901 $278,000
Q1 2021 May 17, 2021	BUY	$14.49 - $20.72 $16,663 - $23,828	1,150 Added 6.99%	17,601 $285,000
Q4 2020 Nov 19, 2021	SELL	$14.61 - $22.14 $92,773 - $140,589	-6,350 Reduced 27.85%	16,451 $348,000
Q4 2020 Feb 18, 2021	BUY	$14.61 - $22.14 $113,227 - $171,585	7,750 Added 51.49%	22,801 $482,000
Q3 2020 Nov 13, 2020	SELL	$13.67 - $17.77 $88,855 - $115,505	-6,500 Reduced 30.16%	15,051 $223,000
Q2 2020 Aug 14, 2020	BUY	$10.89 - $21.47 $11,989 - $23,638	1,101 Added 5.38%	21,551 $317,000
Q1 2020 May 15, 2020	BUY	$10.23 - $24.56 $29,615 - $71,101	2,895 Added 16.49%	20,450 $240,000
Q4 2019 Feb 14, 2020	BUY	$17.42 - $26.61 $305,808 - $467,138	17,555 New	17,555 $412,000

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $127M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.